If you have been reading about AOD-9604 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-06-19. Where a claim depends on a specific study, the study is described rather than over-claimed.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from a fragment of human growth hormone |
| Sequence basis | hGH residues 176-191 | Commonly described as a 16-amino-acid fragment |
| Appearance | White to off-white powder | Typical for lyophilized research peptides |
| Solubility | Soluble in water or aqueous buffer | Exact solubility depends on pH and purity |
| Common synonyms | AOD9604; hGH 176-191 | Spelling and punctuation vary across sources |
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
overseeing the performance of the National Government institutions; approving plans, programmes and policies of the National Government; approving budgets; ratifying international treaties, conventions and agreements; adopting resolutions on matters of public concern; summoning Ministers to answer questions of members of the Assembly on matters related to their ministries; interrogating Ministers about their performance or the performance of their ministries; approving appointments as required by the Transitional Constitution or the law; casting a vote of no confidence against the Vice President and any Minister; enacting legislation to regulate the conditions and terms of service of the Judiciary and its oversight mechanisms; and performing any other function as determined by the Transitional Constitution or the law.
== Compounds == The alkali metals form complete series of compounds with all usually encountered anions, which well illustrate group trends. These compounds can be described as involving the alkali metals losing electrons to acceptor species and forming monopositive ions. This description is most accurate for alkali halides and becomes less and less accurate as cationic and anionic charge increase, and as the anion becomes larger and more polarisable. For instance, ionic bonding gives way to metallic bonding along the series NaCl, Na2O, Na2S, Na3P, Na3As, Na3Sb, Na3Bi, Na.
=== Distilled absinthe === Distilled absinthe employs a method of production similar to that of high-quality gin. Botanicals are initially macerated in distilled base alcohol before being redistilled to exclude bitter principles, and impart the desired complexity and texture to the spirit. The distillation of absinthe first yields a colourless distillate that leaves the alembic at around 72% ABV. The distillate may be reduced and bottled clear, to produce a Blanche or la Bleue absinthe, or it may be coloured to create a verte using natural or artificial colouring. Traditional absinthes obtain their green color strictly from the chlorophyll of whole herbs, which is extracted from the plants during the secondary maceration. This step involves steeping plants such as petite wormwood, hyssop, and melissa (among other herbs) in the distillate. Chlorophyll from these herbs is extracted, giving the drink its famous green color. This step also provides a herbal complexity that is typical of high-quality absinthe. The natural coloring process is critical for absinthe ageing since the chlorophyll remains chemically active. The chlorophyll serves a similar role in absinthe as tannins do in wine or brown liquors. After the coloring process, the resulting product is diluted with water to the desired alcohol percentage. The flavor of absinthe is said to improve materially with storage, and many distilleries, before the ban, aged their absinthe in settling tanks before bottling.
Sources: en.wikipedia.org
== External links == Examination of Leonardo da Vinci's Madonna of the Yarnwinder using PIXE[link removed] Application of PIXE to the study of Renaissance style enameled gold jewelry (PDF) PDI-PIXE-MS: Particle Desorption Ionization Particle-Induced X-Ray Emission Mass Spectrometry (PDF) PIXEMS PNNL031209 – Pacific Northwest National Laboratory Presentation – "Particle Desorption Ionization Particle-Induced X-Ray Emission Mass Spectrometry" – PDI-PIXE-MS. (PDF) Sproch, N., Ashbaugh, M.D., Morse, D., Grant, P., McIntyre Jr., L.C., Antolak, A., Fernando, Q., "PD/PIXE-MS: Particle Desorption Particle Induced X-ray Emission Mass Spectrometry", Proceedings of the 49th ASMS Conference on Mass Spectrometry and Allied Topics; Chicago, Il, May 27 – May 31, 2001.
== Involvement in elections == F2 Logistics has been involved in the distribution of election equipment and paraphernalia in the Philippines. It was the national courier of the Commission on Elections (COMELEC) for the 2018 barangay and Sangguniang Kabataan elections. F2 Logistics has also secured two of four delivery contracts for the 2019 elections. The company has also secured a distribution deal with the COMELEC for the 2022 national elections. The deal has been questioned by Senator Leila de Lima, the National Citizens' Movement for Free Elections, and other civic groups, due to F2 Logistics chairman Dennis Uy's association with incumbent President Rodrigo Duterte, believing that the company has a conflict of interest. Among the company's incorporators include the Duterte administration's executive secretary Salvador Medialdea. The COMELEC dispute the allegation, saying that the awarding of the associated contract was done through public bidding and that F2 Logistics was awarded the deal on the merit that the company offered the lowest responsive bid.
On 13 May 1983, two peat workers at Lindow Moss, Andy Mould and Stephen Dooley, noticed an unusual object—about the size of a football—on the elevator taking peat to the shredding machine. They removed the object for closer inspection, joking that it was a dinosaur egg. Once the peat had been removed, their discovery turned out to be a decomposing, incomplete human head with one eye and some hair intact. Forensics identified the skull as belonging to a European woman, probably aged 30–50. Police initially thought the skull was that of Malika Reyn-Bardt, who had disappeared in 1960 and was the subject of an ongoing investigation. While in prison on another charge, her husband, Peter Reyn-Bardt, had boasted that he had killed his wife and buried her in the back garden of their bungalow, which was on the edge of the area of mossland where peat was being dug. The garden had been examined but no body was found. When Reyn-Bardt was confronted with the discovery of the skull from Lindow Moss, he confessed to the murder of his wife. The skull was later radiocarbon dated, revealing it to be nearly 2,000 years old. "Lindow Woman", as it became known, dated from around 210 AD. This emerged shortly before Reyn-Bardt went to trial, but he was convicted on the evidence of his confession.
=== Widespread application === Since the 1950s, electrophoresis methods have diversified considerably, and new methods and applications are still being developed as affinity electrophoresis, capillary electrophoresis, electroblotting, electrophoretic mobility shift assay, free-flow electrophoresis, isotachophoresis, preparative native PAGE, and pulsed-field gel electrophoresis.
Sources: en.wikipedia.org
No, it is a synthetic peptide fragment corresponding to a small portion of hGH. It is not the full 191-amino-acid hormone and does not reproduce all of hGH's effects.
It is commonly described as a 16-amino-acid peptide based on residues 176-191 of human growth hormone. Some sources vary in notation, so checking the stated sequence is useful.
It is not typically described as a standalone natural hormone. The sequence is derived from the C-terminal region of human growth hormone, but the synthetic peptide is a laboratory-made construct.
Lyophilized powder is commonly stored at −20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept refrigerated and used within a limited period.